These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10356928)

  • 1. [Converting enzyme inhibitors in acute myocardial infarct and heart failure].
    Arslanagić A; Raljević E
    Med Arh; 1999; 53(1):29-31. PubMed ID: 10356928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of angiotensin converting enzyme inhibitor lisinopril on sympathetic heart rate response during exercise in the early phase of acute myocardial infarction].
    Akashi Y; Tanabe K; Osada N; Samejima H; Seki A; Yokoyama Y; Nakayama M; Suzuki N; Oomiya K; Itoh H; Miyake F; Murayama M
    J Cardiol; 2000 Oct; 36(4):221-9. PubMed ID: 11079227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of angiotensin-converting enzyme inhibitors in the treatment of heart failure in the 21st century].
    Gibelin P
    Arch Mal Coeur Vaiss; 2002 Feb; 95 Spec 4(5 Spec 4):41-5. PubMed ID: 11933555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACE inhibitors in cardiovascular disease. Which patient? Which drug? Which dose?
    Pellizzer AM; Krum H
    Aust Fam Physician; 1996 Jul; 25(7):1067-9, 1072-3, 1076-7. PubMed ID: 8768273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of death in patients with acute myocardial infarction treated with angiotensin-converting enzyme inhibitors: findings from the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-3 trial.
    Pedrazzini G; Santoro E; Latini R; Fromm L; Franzosi MG; Mocetti T; Staszewsky L; Barlera S; Tognoni G; Maggioni AP;
    Am Heart J; 2008 Feb; 155(2):388-94. PubMed ID: 18215613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of postinfarction cardiac insufficiency: role of angiotensin converting enzyme inhibitors].
    Guéret P; Cohen-Solal A; Bensaid J
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1709-16. PubMed ID: 1304144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of angiotensin-converting enzyme inhibition on coronary blood flow and infarct size limitation.
    Dargie HJ; Ray SG
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():101-6. PubMed ID: 2674435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks and benefits of early treatment of acute myocardial infarction with an angiotensin-converting enzyme inhibitor in patients with a history of arterial hypertension: analysis of the GISSI-3 database.
    Avanzini F; Ferrario G; Santoro L; Peci P; Giani P; Santoro E; Franzosi MG; Tognoni G;
    Am Heart J; 2002 Dec; 144(6):1018-25. PubMed ID: 12486426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ACE inhibitor or ATII receptor blocker in heart failure and myocardial infarction?].
    Landmark K; Reikvam A
    Tidsskr Nor Laegeforen; 2005 Jan; 125(1):38-40. PubMed ID: 15643463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?
    Packer M
    J Am Coll Cardiol; 1996 Nov; 28(5):1323-7. PubMed ID: 8890833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin does not interact with ACE inhibitors when both are given early after acute myocardial infarction: results of the GISSI-3 Trial.
    Latini R; Santoro E; Masson S; Tavazzi L; Maggioni AP; Franzosi MG; Barlera S; Calvillo L; Salio M; Staszewsky L; Labarta V; Tognoni G;
    Heart Dis; 2000; 2(3):185-90. PubMed ID: 11728260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
    Tokmakova M; Solomon SD
    Curr Opin Cardiol; 2006 Jul; 21(4):268-72. PubMed ID: 16755193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D
    Acta Med Croatica; 2004; 58(2):129-34. PubMed ID: 15208798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pragmatic approach to the use of angiotensin-converting enzyme inhibitors in acute myocardial infarction.
    Vantrimpont P; Rouleau JL
    Can J Cardiol; 1996 Oct; 12(10):924-9. PubMed ID: 9191482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential use of ACE inhibitors after acute myocardial infarction.
    Ambrosioni E; Borghi C
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S92-4. PubMed ID: 2483242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is angiotensin-converting enzyme inhibitor useful in a Japanese population for secondary prevention after acute myocardial infarction? A final report of the Japanese Acute Myocardial Infarction Prospective (JAMP) study.
    Ueshima K; Fukami K; Hiramori K; Hosoda S; Kishida H; Kato K; Fujita T; Tsutani K; Sakuma A;
    Am Heart J; 2004 Aug; 148(2):e8. PubMed ID: 15309011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.